News search

    E.g., 19/12/2025
    E.g., 19/12/2025
    Figure
    Research
    13 Sep 2024
    The RESILIENCE trial: preventing heart injury caused by anticancer drugs

    RESILIENCE is a clinical trial funded by the European Commission (H2020 Programme) that aims to reduce the prevalence of heart failure in cancer survivors
    About the CNIC
    12 Sep 2024
    Join CNIC through CURE HEART AND BRAIN (COFUND)
    CNIC researchers
    Research
    30 Aug 2024
    Nature Medicine: CNIC scientists discover a new cardiovascular risk factor and identify a drug able to reduce its effects

    Two studies carried out at the CNIC provide key information about a newly identified cardiovascular risk factor, clonal hematopoiesis, and its treatment with the ancient medication colchicine
    Rebecca F. Gottesman
    Research
    4 Jun 2024
    Rebecca F. Gottesman: “Telling someone their risk of dementia would drop if they treated their high blood pressure would impact them more than the possibility of a heart attack or stroke"

    Stroke Branch Chief at the National Institute of Neurological Disorders and Stroke (NINDS)
    Dr. Fuster recibe el premio
    About the CNIC
    27 May 2024
    Dr Valentín Fuster receives the prestigious Lifetime Achievement Award of the World Heart Federation (WHF
    Michael A. Laflamme y David Filgueiras
    Research
    3 May 2024
    Michael A. Laflamme: “Sooner or later we will manage to regenerate the heart”
    María Jesús Andrés, Carla Espinós (detrás), Rosa M Nevado (delante, al lado de MJA), Miguel de la Fuente, Rosa Carmona, Ana Barettino, Vicente Andrés, Pilar Gonzalo e Ignacio Benedicto.
    Research
    19 Apr 2024
    PNAS: CNIC scientists identify the key cell type for strategies to prevent atherosclerosis in progeria syndrome

    The elimination of progerin from vascular smooth muscle cells, but not from endothelial cells, prevents the atherosclerosis associated with Hutchinson-Gilford progeria syndrome (HGPS)
    Agustín Clemente-Moragón, Borja Ibáñez, Anabel Díaz-Guerra, Laura Cádiz, Carlos Galán-Arriola, Miguel Fernández-Tocino, Mónica Gómez, Rocío Villena-Gutiérrez, y Eduardo Oliver.
    Research
    16 Apr 2024
    JACC: CardioOncology: CNIC scientists identify therapeutic targets for the prevention of heart injury linked to cancer treatment

    The study, published in the journal JACC: CardioOncology, identifies mitochondrial function and heart metabolism as targets for possible treatments to protect against anthracycline-induced cardiotoxicity
    Paul Rilay: "Soy muy optimista sobre el futuro"
    Research
    3 Feb 2024
    Paul Rilay: "I’m optimistic about the future"

    British Heart Foundation
    Carlos Torroja, Jacob F. Bentzon, Paula Nogales, Laura Carramolino, Vanessa Cumbicus, Daniel Morales, Ana Dopazo, Verónica Labrador y Alberto Benguria
    Research
    1 Feb 2024
    Nature Cardiovascular Research: New approach to the design of therapies that enhance the effect of cholesterol-lowering drugs

    A study published in Nature Cardiovascular Research reveals smooth muscle-derived cells as a new target for reducing the size of atherosclerotic plaque. The results open up new avenues for the design of treatments to enhance the beneficial effect of cholesterol-lowering drugs